VR Logo

Cipla Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Incorporated: 1935

Chairman: Y K Hamied

Managing Director: Umang Vohra

Group: Cipla

Listing: NSE: CIPLA, BSE: 500087

Headquarters: Mumbai, Maharashtra

Website: www.cipla.com

Key Facts

Market cap: R 51,508.62 Cr

Revenue (TTM): R 17,131.99 Cr

Earnings (TTM): R 1,546.98 Cr

Cash: R 2,744.60 Cr

Total Debt: R 4,316.23 Cr

Promoters' ownership: 36.68%

Liquidity: High

52 Week range: R 355.30 - 696.00

Face value: R2.00

Shares outstanding: 80,62,71,001

10 Years Aggregate:

  • CFO: 15,191.77 Cr
  • EBITDA: 20,870.65 Cr
  • Net Profit: 12,779.91 Cr

Stock Performance

Time Period Cipla S&P BSE Sensex S&P BSE Healthcare
YTD33.58-12.6821.71
1 month-0.375.613.20
3 months42.2130.5631.86
1 Year15.46-9.5826.34
3 Years4.994.884.73
5 Years0.235.09-0.39
10 Years6.607.5011.08
As on 03-Jul-2020
Year Cipla S&P BSE Sensex S&P BSE Healthcare
2019-8.5714.38-3.55
2018-14.555.87-5.89
20176.9827.910.49
2016-13.211.95-12.88
20153.40-5.0315.06
201455.9229.8947.43
2013-3.998.9822.55